Together, these findings identify a previously unrecognized mechanism by which TDP-43 impairs glycolysis through HK1 misregulation and highlight glycolytic restoration as a potential therapeutic strategy in ALS. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.